Neither fibrin nor plasminogen activator inhibitor-1 deficiency protects lung function in a mouse model of acute lung injury

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 296, Issue 3, 2009, Pages

  Allen, Gilman B ^a,b,e   Cloutier, Mary E ^a   Larrabee, Yuna C ^a   Tetenev, Konstantin ^a,d   Smiley, Stephen T ^c   Bates, Jason H T ^a,b  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^b FLETCHER ALLEN HEALTH CARE   (United States)

^c TRUDEAU INSTITUTE   (United States)

^d SIBERIAN STATE MEDICAL UNIVERSITY   (Russian Federation)

^e HSRF   (United States)

Author keywords

Acid aspiration; Coagulation; Lung mechanics; Respiratory impedance

Indexed keywords

BIOLOGICAL MARKER; FIBRIN; HYDROCHLORIC ACID; LUNG SURFACTANT; PLASMINOGEN ACTIVATOR INHIBITOR 1; AUTACOID; FIBRINOGEN; SERINE PROTEINASE INHIBITOR; SERPINE2 PROTEIN, MOUSE;

ACUTE LUNG INJURY; AIRWAY RESISTANCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD CLOTTING; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FIBRINOLYSIS; IMMUNOHISTOCHEMISTRY; LUNG FUNCTION; LUNG MECHANICS; MOUSE; NONHUMAN; OSCILLATION; PERMEABILITY; POSITIVE END EXPIRATORY PRESSURE; PRESSURE VOLUME CURVE; PRIORITY JOURNAL; WESTERN BLOTTING; AFIBRINOGENEMIA; ANIMAL; BREATHING MECHANICS; C57BL MOUSE; CHEMISTRY; DISEASE MODEL; GENETICS; LUNG; LUNG LAVAGE; MOUSE MUTANT; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY;

ACUTE LUNG INJURY; AFIBRINOGENEMIA; ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; DISEASE MODELS, ANIMAL; FEMALE; FIBRIN; FIBRINOGEN; INFLAMMATION MEDIATORS; LUNG; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RESPIRATORY MECHANICS; SERPINS;

EID: 64249112624     PISSN: 10400605     EISSN: 15221504     Source Type: Journal    
DOI: 10.1152/ajplung.90475.2008     Document Type: Article

References (65)

1. Abraham E, Reinhart K, Opal S, Demeyer I, Doig C, Rodriguez AL, Beale R, Svoboda P, Laterre PF, Simon S, Light B, Spapen H, Stone J, Seibert A, Peckelsen C, De Deyne C, Postier R, Pettila V, Artigas A, Percell SR, Shu V, Zwingelstein C, Tobias J, Poole L, Stolzenbach JC, Creasey AA. Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis: a randomized controlled trial. JAMA 290: 238-247, 2003. (Pubitemid 37430063)
2. Abubakar K, Schmidt B, Monkman S, Webber C, deSA D, Roberts R. Heparin improves gas exchange during experimental acute lung injury in newborn piglets. Am J Respir Crit Care Med 158: 1620-1625, 1998. (Pubitemid 28536629)
3. Allen G, Bates JH. Dynamic mechanical consequences of deep inflation in mice depend on type and degree of lung injury. J Appl Physiol 96: 293-300, 2004. (Pubitemid 38032013)
4. Allen GB, Cloutier ME, Larrabee YC, Smiley ST, Bates JHT. Neither fibrinogen nor PAI-1 deficiency confers protection of lung mechanical function in a mouse model of acute lung injury (Abstract). Am J Respir Crit Care Med 177: A62, 2008.
5. Allen GB, Leclair T, Cloutier M, Thompson-Figueroa J, Bates JH. The response to recruitment worsens with progression of lung injury and fibrin accumulation in a mouse model of acid aspiration. Am J Physiol Lung Cell Mol Physiol 292: L1580-L1589, 2007. (Pubitemid 47077374)
6. Allen GB, Pavone LA, DiRocco JD, Bates JHT, Nieman GF. Pulmonary impedance and alveolar instability during injurious ventilation in rats. J Appl Physiol 99: 723-730, 2005.
7. Arndt PG, Young SK, Poch KR, Nick JA, Falk S, Schrier RW, Worthen GS. Systemic inhibition of the angiotensin-converting enzyme limits lipopolysaccharide-induced lung neutrophil recruitment through both bradykinin and angiotensin II-regulated pathways. J Immunol 177: 7233-7241, 2006.
8. Barazzone C, Belin D, Piguet PF, Vassalli JD, Sappino AP. Plasminogen activator inhibitor-1 in acute hyperoxic mouse lung injury. J Clin Invest 98: 2666-2673, 1996. (Pubitemid 26427390)
9. Bates JH, Allen GB. The estimation of lung mechanics parameters in the presence of pathology: a theoretical analysis. Ann Biomed Eng 34: 384-392, 2006.
10. Bertozzi P, Astedt B, Zenzius L, Lynch K, LeMaire F, Zapol W, Chapman HA Jr. Depressed bronchoalveolar urokinase activity in patients with adult respiratory distress syndrome. N Engl J Med 322: 890-897, 1990. (Pubitemid 20108378)
11. Carmeliet P, Stassen JM, Schoonjans L, Ream B, van den Oord JJ, De Mol M, Mulligan RC, Collen D. Plasminogen activator inhibitor-1 gene-deficient mice. II. Effects on hemostasis, thrombosis, and thrombolysis. J Clin Invest 92: 2756-2760, 1993. (Pubitemid 24006541)
12. Dahlem P, Bos AP, Haitsma JJ, Schultz MJ, Meijers JC, Lachmann B. Alveolar fibrinolytic capacity suppressed by injurious mechanical ventilation. Intensive Care Med 31: 724-732, 2005. (Pubitemid 40684993)
13. Dahlem P, Bos AP, Haitsma JJ, Schultz MJ, Wolthuis EK, Meijers JC, Lachmann B. Mechanical ventilation affects alveolar fibrinolysis in LPS-induced lung injury. Eur Respir J 28: 992-998, 2006. (Pubitemid 46331970)
14. Davidson KG, Bersten AD, Barr HA, Dowling KD, Nicholas TE, Doyle IR. Lung function, permeability, and surfactant composition in oleic acid-induced acute lung injury in rats. Am J Physiol Lung Cell Mol Physiol 279: L1091-L1102, 2000.
15. Eitzman DT, McCoy RD, Zheng X, Fay WP, Shen T, Ginsburg D, Simon RH. Bleomycin-induced pulmonary fibrosis in transgenic mice that either lack or overexpress the murine plasminogen activator inhibitor-1 gene. J Clin Invest 97: 232-237, 1996. (Pubitemid 26021713)
16. Enkhbaatar P, Murakami K, Cox R, Westphal M, Morita N, Brantley K, Burke A, Hawkins H, Schmalstieg F, Traber L, Herndon D, Traber D. Aerosolized tissue plasminogen inhibitor improves pulmonary function in sheep with burn and smoke inhalation. Shock 22: 70-75, 2004. (Pubitemid 40228213)
17. Esmon CT. Interactions between the innate immune and blood coagulation systems. Trends Immunol 25: 536-542, 2004.
18. Ge M, Ryan TJ, Lum H, Malik AB. Fibrinogen degradation product fragment D increases endothelial monolayer permeability. Am J Physiol Lung Cell Mol Physiol 261: L283-L289, 1991.
19. Gomes RF, Shen X, Ramchandani R, Tepper RS, Bates JH. Comparative respiratory system mechanics in rodents. J Appl Physiol 89: 908-916, 2000. (Pubitemid 32125388)
20. Gross TJ, Leavell KJ, Peterson MW. CD11b/CD18 mediates the neutrophil chemotactic activity of fibrin degradation product D domain. Thromb Haemost 77: 894-900, 1997.
21. Gunasekara L, Schurch S, Schoel WM, Nag K, Leonenko Z, Haufs M, Amrein M. Pulmonary surfactant function is abolished by an elevated proportion of cholesterol. Biochim Biophys Acta 1737: 27-35, 2005. (Pubitemid 41550380)
22. Gunther A, Lubke N, Ermert M, Schermuly RT, Weissmann N, Breithecker A, Markart P, Ruppert C, Quanz K, Ermert L, Grimminger F, Seeger W. Prevention of bleomycin-induced lung fibrosis by aerosolization of heparin or urokinase in rabbits. Am J Respir Crit Care Med 168: 1358-1365, 2003. (Pubitemid 37487332)
23. Gunther A, Mosavi P, Heinemann S, Ruppert C, Muth H, Markart P, Grimminger F, Walmrath D, Temmesfeld-Wollbruck B, Seeger W. Alveolar fibrin formation caused by enhanced procoagulant and depressed fibrinolytic capacities in severe pneumonia. Comparison with the acute respiratory distress syndrome. Am J Respir Crit Care Med 161: 454-462, 2000. (Pubitemid 30129452)
24. Han X, Fink MP, Uchiyama T, Yang R, Delude RL. Increased iNOS activity is essential for pulmonary epithelial tight junction dysfunction in endotoxemic mice. Am J Physiol Lung Cell Mol Physiol 286: L259-L267, 2004. (Pubitemid 38129506)
25. Hantos Z, Daroczy B, Suki B, Nagy S, Fredberg JJ. Input impedance and peripheral inhomogeneity of dog lungs. J Appl Physiol 72: 168-178, 1992.
26. Hattori N, Degen JL, Sisson TH, Liu H, Moore BB, Pandrangi RG, Simon RH, Drew AF. Bleomycin-induced pulmonary fibrosis in fibrinogen-null mice. J Clin Invest 106: 1341-1350, 2000.
27. Hirai T, McKeown KA, Gomes RF, Bates JH. Effects of lung volume on lung and chest wall mechanics in rats. J Appl Physiol 86: 16-21, 1999. (Pubitemid 29046935)
28. Idell S. Coagulation, fibrinolysis, and fibrin deposition in acute lung injury. Crit Care Med 31: S213-S220, 2003. (Pubitemid 36458170)
29. Idell S, James KK, Levin EG, Schwartz BS, Manchanda N, Maunder RJ, Martin TR, McLarty J, Fair DS. Local abnormalities in coagulation and fibrinolytic pathways predispose to alveolar fibrin deposition in the adult respiratory distress syndrome. J Clin Invest 84: 695-705, 1989. (Pubitemid 19197006)
30. Jian MY, Koizumi T, Tsushima K, Fujimoto K, Kubo K. Activated protein C attenuates acid-aspiration lung injury in rats. Pulm Pharmacol Ther 18: 291-296, 2005. (Pubitemid 40379752)
31. Johnson LL, Berggren KN, Szaba FM, Chen W, Smiley ST. Fibrin-mediated protection against infection-stimulated immunopathology. J Exp Med 197: 801-806, 2003. (Pubitemid 36350874)
32. Kawkitinarong K, Linz-McGillem L, Birukov KG, Garcia JG. Differential regulation of human lung epithelial and endothelial barrier function by thrombin. Am J Respir Cell Mol Biol 31: 517-527, 2004. (Pubitemid 39463400)
33. Laterre PF, Wittebole X, Dhainaut JF. Anticoagulant therapy in acute lung injury. Crit Care Med 31: S329-S336, 2003. (Pubitemid 36458188)
34. Leavell KJ, Peterson MW, Gross TJ. The role of fibrin degradation products in neutrophil recruitment to the lung. Am J Respir Cell Mol Biol 14: 53-60, 1996.
35. Lee MM, Green FH, Schurch S, Cheng S, Bjarnason SG, Leonard S, Wallace W, Possmayer F, Vallyathan V. Comparison of inhibitory effects of oxygen radicals and calf serum protein on surfactant activity. Mol Cell Biochem 259: 15-22, 2004. (Pubitemid 38519211)
36. Lutchen KR, Greenstein JL, Suki B. How inhomogeneities and airway walls affect frequency dependence and separation of airway and tissue properties. J Appl Physiol 80: 1696-1707, 1996. (Pubitemid 26143920)
37. Lutchen KR, Hantos Z, Petak F, Adamicza A, Suki B. Airway inhomogeneities contribute to apparent lung tissue mechanics during constriction. J Appl Physiol 80: 1841-1849, 1996. (Pubitemid 26143938)
38. Marshall R, Bellingan G, Laurent G. The acute respiratory distress syndrome: fibrosis in the fast lane. Thorax 53: 815-817, 1998. (Pubitemid 28459534)
39. Marshall RP, Bellingan G, Webb S, Puddicombe A, Goldsack N, McAnulty RJ, Laurent GJ. Fibroproliferation occurs early in the acute respiratory distress syndrome and impacts on outcome. Am J Respir Crit Care Med 162: 1783-1788, 2000.
40. Martin C, Papazian L, Payan MJ, Saux P, Gouin F. Pulmonary fibrosis correlates with outcome in adult respiratory distress syndrome. A study in mechanically ventilated patients. Chest 107: 196-200, 1995.
41. Marzan Y, Mora R, Butler A, Butler M, Ingenito EP. Effects of simultaneous exposure of surfactant to serum proteins and free radicals. Exp Lung Res 28: 99-121, 2002. (Pubitemid 34164084)
42. Matamis D, Lemaire F, Harf A, Brun-Buisson C, Ansquer JC, Atlan G. Total respiratory pressure-volume curves in the adult respiratory distress syndrome. Chest 86: 58-66, 1984. (Pubitemid 14088029)
43. Mullarky IK, Szaba FM, Berggren KN, Parent MA, Kummer LW, Chen W, Johnson LL, Smiley ST. Infection-stimulated fibrin deposition controls hemorrhage and limits hepatic bacterial growth during listeriosis. Infect Immun 73: 3888-3895, 2005. (Pubitemid 40923126)
44. Panda AK, Nag K, Harbottle RR, Rodriguez-Capote K, Veldhuizen RA, Petersen NO, Possmayer F. Effect of acute lung injury on structure and function of pulmonary surfactant films. Am J Respir Cell Mol Biol 30: 641-650, 2004. (Pubitemid 38591215)
45. Prabhakaran P, Ware LB, White KE, Cross MT, Matthay MA, Olman MA. Elevated levels of plasminogen activator inhibitor-1 in pulmonary edema fluid are associated with mortality in acute lung injury. Am J Physiol Lung Cell Mol Physiol 285: L20-L28, 2003. (Pubitemid 36736464)
46. Renckens R, Roelofs JJ, Bonta PI, Florquin S, de Vries CJ, Levi M, Carmeliet P, van't Veer C, van der Poll T. Plasminogen activator inhibitor type 1 is protective during severe Gram-negative pneumonia. Blood 109: 1593-1601, 2007. (Pubitemid 46239593)
47. Rijneveld AW, Florquin S, Bresser P, Levi M, De Waard V, Lijnen R, Van Der Zee JS, Speelman P, Carmeliet P, Van Der Poll T. Plasminogen activator inhibitor type-1 deficiency does not influence the outcome of murine pneumococcal pneumonia. Blood 102: 934-939, 2003. (Pubitemid 36917786)
48. Rowland FN, Donovan MJ, Picciano PT, Kreutzer DL. Fibrin-mediated vascular injury: demonstration of vascular endothelial cell retraction in response to soluble fibrin-associated factors. J Exp Pathol 1: 217-240, 1984.
49. Rubenfeld GD, Caldwell E, Peabody E, Weaver J, Martin DP, Neff M, Stern EJ, Hudson LD. Incidence and outcomes of acute lung injury. N Engl J Med 353: 1685-1693, 2005. (Pubitemid 41464707)
50. Schermuly RT, Gunther A, Weissmann N, Ghofrani HA, Seeger W, Grimminger F, Walmrath D. Differential impact of ultrasonically nebulized versus tracheal-instilled surfactant on ventilation-perfusion (VA/Q) mismatch in a model of acute lung injury. Am J Respir Crit Care Med 161: 152-159, 2000. (Pubitemid 30055918)
51. Schuessler TF, Bates JH. A computer-controlled research ventilator for small animals: design and evaluation. IEEE Trans Biomed Eng 42: 860-866, 1995.
52. Seeger W, Grube C, Gunther A, Schmidt R. Surfactant inhibition by plasma proteins: differential sensitivity of various surfactant preparations. Eur Respir J 6: 971-977, 1993. (Pubitemid 23221331)
53. Seeger W, Gunther A, Thede C. Differential sensitivity to fibrinogen inhibition of SP-C- vs. SP-B-based surfactants. Am J Physiol Lung Cell Mol Physiol 262: L286-L291, 1992.
54. Seeger W, Stohr G, Wolf HR, Neuhof H. Alteration of surfactant function due to protein leakage: special interaction with fibrin monomer. J Appl Physiol 58: 326-338, 1985. (Pubitemid 15057739)
55. Smyth SS, Reis ED, Vaananen H, Zhang W, Coller BS. Variable protection of beta 3-integrin-deficient mice from thrombosis initiated by different mechanisms. Blood 98: 1055-1062, 2001.
56. Suh TT, Holmback K, Jensen NJ, Daugherty CC, Small K, Simon DI, Potter S, Degen JL. Resolution of spontaneous bleeding events but failure of pregnancy in fibrinogen-deficient mice. Genes Dev 9: 2020-2033, 1995.
57. Tasaki O, Mozingo DW, Dubick MA, Goodwin CW, Yantis LD, Pruitt BA Jr. Effects of heparin and lisofylline on pulmonary function after smoke inhalation injury in an ovine model. Crit Care Med 30: 637-643, 2002. (Pubitemid 34214630)
58. Tomashefski JF Jr. Pulmonary pathology of acute respiratory distress syndrome. Clin Chest Med 21: 435-466, 2000.
59. Vassalli JD, Sappino AP, Belin D. The plasminogen activator/plasmin system. J Clin Invest 88: 1067-1072, 1991.
60. Ware LB, Matthay MA. The acute respiratory distress syndrome. N Engl J Med 342: 1334-1349, 2000.
61. Ware LB, Matthay MA, Parsons PE, Thompson BT, Januzzi JL, Eisner MD. Pathogenetic and prognostic significance of altered coagulation and fibrinolysis in acute lung injury/acute respiratory distress syndrome. Crit Care Med 35: 1821-1828, 2007.
62. Warren BL, Eid A, Singer P, Pillay SS, Carl P, Novak I, Chalupa P, Atherstone A, Penzes I, Kubler A, Knaub S, Keinecke HO, Heinrichs H, Schindel F, Juers M, Bone RC, Opal SM. Caring for the critically ill patient. High-dose antithrombin III in severe sepsis: a randomized controlled trial. JAMA 286: 1869-1878, 2001.
63. Welty-Wolf KE, Carraway MS, Ortel TL, Piantadosi CA. Coagulation and inflammation in acute lung injury. Thromb Haemost 88: 17-25, 2002.
64. Wilson TA, Anafi RC, Hubmayr RD. Mechanics of edematous lungs. J Appl Physiol 90: 2088-2093, 2001.
65. Wojta J, Gallicchio M, Zoellner H, Hufnagl P, Last K, Filonzi EL, Binder BR, Hamilton JA, McGrath K. Thrombin stimulates expression of tissue-type plasminogen activator and plasminogen activator inhibitor type 1 in cultured human vascular smooth muscle cells. Thromb Haemost 70: 469-474, 1993. (Pubitemid 23254678)